Trending...
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Spokane: City to Temporarily Close Pedestrian Access to Browne St Viaduct
- Spokane: Impacts For Final Stretch of Construction Season
SEATTLE, April 9, 2021 /PRNewswire/ -- Today, FidaLab, a CLIA-certified clinical diagnostic company based in Seattle announced its partnership with Concentric by Ginkgo to provide a scalable and simple testing modality - pooled testing - to serve K-12 schools.
As more and more schools work to support in-person learning environments, communities across the country have turned to COVID-19 testing to monitor the virus. Even as teachers and guardians become eligible for vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts to track and mitigate viral spread remain critical.
Concentric by Ginkgo's goal is to provide easy, affordable pooled testing to every school in America. Pooled classroom testing, which combines swabs from all consenting individuals in a classroom and runs them as a single test can significantly increase testing capacity and lower the cost of testing programs. Over 800 hundred schools are currently signed up to test with Concentric across the country.
"We are excited at the prospect of joining Ginkgo to provide mass COVID testing in schools to help maintain in-person learning environments in Washington. Ginkgo has proven itself in successfully implementing school testing programs in the State of Massachusetts, Maryland, and beyond. The combination of our local testing capability and Ginkgo's experience and organizational strength will provide a very reliable option for Washington school systems," said Myles Yu, Chief Medical Officer of FidaLab.
More on Washingtoner
On February 17, 2021, the U.S. Department of Health and Human Services (HHS) in partner with the Department of Defense (DOD) has announced a $650 million investment to expand COVID-19 testing capacity for K-8 schools to support President Biden's plan to re-open schools for in-person learning.
"The funding provided by the Biden Administration will help make it possible for schools in Washington and across the country to engage in pooled testing for every student, every week," said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. "Testing in schools will support the entire community by providing opportunities to limit the spread, and to interrupt chains of transmission."
FidaLab joined the fight against the COVID-19 pandemic at the very beginning and has built massive PCR testing capability for SARS-CoV-2, the virus that causes COVID-19. FidaLab has provided mass testing in collaboration with large scale county testing, schools, long term care facilities, athletic teams and more.
To learn more about Concentric by Ginkgo or to get your school district involved, head over to concentricbyginkgo.com.
About FidaLab
FidaLab is a privately owned CLIA-certified clinical laboratory based in Seattle with a specialty in molecular diagnosis of infectious diseases using cutting edge biotechnologies. With its proven diagnostic accuracy and 24-hour turnaround time, FidaLab has earned the trust of the communities it serves.
More on Washingtoner
About Ginkgo Bioworks
Concentric by Ginkgo is Ginkgo Bioworks' public health and biosecurity effort. Headquartered in Boston, Ginkgo uses the most advanced technology on the planet—biology—to grow better products. The company's cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contact:
[email protected]
FidaLab Contact:
[email protected]
Related Images
image1.jpg
SOURCE FidaLab LLC
As more and more schools work to support in-person learning environments, communities across the country have turned to COVID-19 testing to monitor the virus. Even as teachers and guardians become eligible for vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts to track and mitigate viral spread remain critical.
Concentric by Ginkgo's goal is to provide easy, affordable pooled testing to every school in America. Pooled classroom testing, which combines swabs from all consenting individuals in a classroom and runs them as a single test can significantly increase testing capacity and lower the cost of testing programs. Over 800 hundred schools are currently signed up to test with Concentric across the country.
"We are excited at the prospect of joining Ginkgo to provide mass COVID testing in schools to help maintain in-person learning environments in Washington. Ginkgo has proven itself in successfully implementing school testing programs in the State of Massachusetts, Maryland, and beyond. The combination of our local testing capability and Ginkgo's experience and organizational strength will provide a very reliable option for Washington school systems," said Myles Yu, Chief Medical Officer of FidaLab.
More on Washingtoner
- JoCa's Echoes of Haworth Sells Out on Opening Night in Mexico City; Artist Heads to San Luis Potosí and Miami Art Week
- Home2 Suites by Hilton Lee's Summit, MO Opens to Guests
- Shanghai Chengwei Semiconductor Equipment Launches High Precision Laboratory Central Gas Supply System
- Your Local Pro Expands National Service Network to 273+ Locations Across Plumbing, Cleaning, Landscaping and Hydrovac
- Acuvance Coker Study Finds Experience, Not Supply, Is the Biggest Advanced Practice Provider Workforce Challenge
On February 17, 2021, the U.S. Department of Health and Human Services (HHS) in partner with the Department of Defense (DOD) has announced a $650 million investment to expand COVID-19 testing capacity for K-8 schools to support President Biden's plan to re-open schools for in-person learning.
"The funding provided by the Biden Administration will help make it possible for schools in Washington and across the country to engage in pooled testing for every student, every week," said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. "Testing in schools will support the entire community by providing opportunities to limit the spread, and to interrupt chains of transmission."
FidaLab joined the fight against the COVID-19 pandemic at the very beginning and has built massive PCR testing capability for SARS-CoV-2, the virus that causes COVID-19. FidaLab has provided mass testing in collaboration with large scale county testing, schools, long term care facilities, athletic teams and more.
To learn more about Concentric by Ginkgo or to get your school district involved, head over to concentricbyginkgo.com.
About FidaLab
FidaLab is a privately owned CLIA-certified clinical laboratory based in Seattle with a specialty in molecular diagnosis of infectious diseases using cutting edge biotechnologies. With its proven diagnostic accuracy and 24-hour turnaround time, FidaLab has earned the trust of the communities it serves.
More on Washingtoner
- Molecular Hydrogen Syngergists - Webinar by Dr. Bruce Berkowsky
- Spokane: 18-Year-Old Male Deceased After Fatal Motorcycle Collision
- Uk Financial Moonshot Token™ Robinhood-chain Goes Live On Tokpie Exchange Tomorrow, With Solana Side Of UKFLMS To Follow In Global Listing Expansion
- Spokane: Tree Trot 5k Fun Run October 3 at Finch Arboretum
- TBM Council Launches Global E-Learning Platform to Drive Role Fluency
About Ginkgo Bioworks
Concentric by Ginkgo is Ginkgo Bioworks' public health and biosecurity effort. Headquartered in Boston, Ginkgo uses the most advanced technology on the planet—biology—to grow better products. The company's cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contact:
[email protected]
FidaLab Contact:
[email protected]
Related Images
image1.jpg
SOURCE FidaLab LLC
0 Comments
Latest on Washingtoner
- Century Fasteners Corp. Exhibiting at the 2026 International Fastener Expo
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
- Tacoma: 'Preparing the Bid' Workshop on October 19
- Tacoma: Street Operations Crew Scheduled to Conduct Snow and Ice Training October 12 – 14
- Bank Statement Loans Up to $30 Million: Lendmire Announces High-Net-Worth Financing
- Guberman to Business Owners, Implant Patients: Your ISO 9001,ISO 13485 AS9100,AI9100 Certificate Is Dead, and Nobody Knows What's Inside You
- NYC Big Book Award Celebrates 10th Anniversary with Announcement of 2026 Winners
- Squaawke Releases a Hymn-Cycle Written for Intelligent Machines
- Tickeron Launches New AI Trading Robots for Semi & Finance with Profit Factor 2.8 for Hedge Funds (JPM, BAC, NVDA, GOOG, AVGO, META, AMD)
- Regional Magazines Shine at IRMA Awards
- Spokane: Impacts For Final Stretch of Construction Season
- Kocer Consulting & Engineering's Dan Kocer Named 2026 PNAA Chair Award Recipient
- Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
- Sawgrass Ford President Attributes Dealerships Success to Long-Term Employees
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity